Vaccines

Peanut allergies could become a thing of the past as breakthrough research from the University of South Australia develops a radically novel vaccination that's poised to cure the potentially life threatening condition. The vaccine…

Research undertaken by King's College London and St George's, University of London has found that introducing certain foods early to infants can prevent them from developing an allergy despite low adherence to an introduction regime.…

Study finds VR might provide a path to increased acceptanceCredit: Sarah Freeman Athens, Ga. - Using a virtual reality simulation to show how flu spreads and its impact on others could be a way to encourage more people to get a flu…

EAST LANSING, Mich. - Each year millions of Americans become sick with the flu, hundreds of thousands are hospitalized and tens of thousands die. Getting the flu shot can reduce the chances of infection. But, at best, the vaccine is only…

1.7 million. That's how many people are infected with the human immunodeficiency virus (HIV) each year worldwide. 1.7 million people who are condemned to lifelong antiretroviral therapy (ART) or risk developing fatal AIDS . Out of the…

Researchers from Queen Mary University of London and Zhengzhou University have developed a personalised vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the…

Using whole genome sequencing, researchers have been able to trace the origins and global spread of a multi-drug resistant, community Staphylococcus aureus lineage from the Indian subcontinent, known as the Bengal Bay clone Staphylococcus…

New evidence published in the Cochrane Library today provides further information on the benefits and harms of different human papillomavirus (HPV) vaccines and vaccine schedules in young women and men. HPV is the most common viral…

Vaccinated rabbits produce antibodies to at least two vulnerable sites on HIV LA JOLLA, CA - An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an…

Credit: Photo by Johan Wingborg University of Gothenburg reports first successful results of the oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants and…